Dutch Biomarker Firm ACS Biomarker Closes Financing, Appoints New CEO

The funds will be used to further develop its product pipeline and discover novel biomarkers for cardiovascular diseases.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories